via drugtargetreview.com
A group of researchers has found a new way to limit excessive immune responses, which may point in a new direction for research in and treatment of e.g. autoimmune diseases.
Researchers from Aarhus University Hospital and Aarhus University in Denmark in collaboration with researchers from Colorado in the United States have found a new way to treat the inflammation involved in chronic diseases such as psoriasis, asthma and HIV. A group of transmitter substances (cytokines) in the immune system, the so-called IL-1 family, has been shown to play an important role in many of these diseases by regulating the body’s immune responses.
Professor Charles A. Dinarello from University of Colorado Denver is also an honorary doctor at Aarhus University. He is an expert in regulation and transmission of these cytokines. He is primarily known for discovering the important cytokine IL-1(-?), which plays an important role in countless diseases. In collaboration with Charles Dinarello, the Danish researchers have investigated a more efficient way of reducing the effect of the IL-1 family and in this way improve treatment of chronic inflammatory diseases.
Previous research has often focused on blocking a single cytokine or signaling pathway at a time. However, many diseases and sequela are driven by more than one cytokine. This has caused researchers to wonder if it could be possible to block more important signaling pathways of the IL-1 family at the same time, and in this way make it possible to develop better treatments. The researchers try to find a broader anti-inflammatory treatment impacting several important cytokines at the same time, but also trying to avoid that this causes unintended side-effects.
In this study, the researchers have investigated if a receptor (IL-1R3), which is not just involved in the signaling of one but six different inflammatory cytokines in the IL-1 family, could be a possible target in the treatment of chronic inflammatory disease. Using an antibody to block the effect of IL-1R3, it was possible for the researchers to investigate the effects in both studies on cells and mice.
In this way, researchers could study some of the consequences of the blocking of this receptor on the immune system. At the same time, the researchers specifically studied the effect of blocking IL-1R3 in mice with either gout, acute allergic inflammation (asthma) or psoriasis.
– The experiments showed that it was possible to effectively block the receptor and reduce manifestation of diseases, which underlines the potentials in our new approach, says MD and PhD Jesper Falkesgaard Højen.
– Even though new questions arise as a consequences of these results, we have managed to describe a new and effective approach to block IL-1 family driven inflammation, and in this way we have possibly contributed with a new direction to study and treat chronic inflammatory conditions driven by the IL-1 family.
Learn more: Danish-American research presents new ways of developing treatment of chronic inflammation
The Latest on: Autoimmune diseases
via Google News
The Latest on: Autoimmune diseases
- New approach needed to study autoimmune diseaseson January 10, 2021 at 8:27 pm
A research team has recently determined that the Immune only focus of the current research must be updated to better understand autoimmune diseases such as type 1 diabetes and multiple sclerosis.
- Feeling exhausted? Could you be one of the 10pc of Kiwi women who have this Autoimmune Disease?on January 10, 2021 at 3:31 pm
Sometimes it seems as though everyone in my age group is feeling worn-out, run-down, not sleeping well – and are all more than happy to volunteer up this information. We all like the constant ...
- Ginger Compound Demonstrates Protective Role against Autoimmune Disorders in Miceon January 8, 2021 at 5:00 am
Ginger root compound lowered autoantibody production, NETs, and helped inhibit disease progression in mice with APS and lupus.
- Investigation Explores Relationship Between Psoriasis and Autoimmune Disorderson January 7, 2021 at 2:23 pm
Patients with psoriasis may be more likely to have additional autoimmune disorders, including vitiligo, diabetes, autoimmune thyroiditis, rheumatoid arthritis, and inflammatory bowel disease.
- BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Scienceon January 7, 2021 at 11:34 am
Collaborative study of BioNTech with TRON and the University Medical Center and Research Center for Immunotherapy at Johannes Gutenberg University of Mainz introduces novel non-inflammatory mRNA ...
- Common gene expression changes at target tissues of four autoimmune diseases foundon January 7, 2021 at 6:15 am
Autoimmune diseases are diseases of "mistaken identity", where the immune system - which is supposed to protect us against infectious diseases and neoplasias - mistakenly attacks and destroys ...
- New approach can help identify novel treatments for autoimmune diseaseson January 6, 2021 at 10:56 pm
A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, PhD, has found that identifying new treatments for autoimmune ...
- A new approach to study autoimmune diseaseson January 6, 2021 at 2:18 pm
A team of researchers led by the Indiana Biosciences Research Institute Diabetes Center's Scientific Director Decio L. Eizirik, MD, Ph.D., has found that identifying new treatments for autoimmune ...
- New research finds ginger counters certain autoimmune diseases in miceon January 6, 2021 at 11:59 am
The main bioactive compound of ginger root lowers autoantibody production and helps halt disease progression in mice with antiphospholipid syndrome and lupus.
- No evidence COVID-19 vaccines lead to autoimmune diseaseon January 5, 2021 at 1:35 pm
CLAIM: COVID-19 vaccines that rely on messenger RNA technology will teach the body to attack itself, leading to autoimmune disease. AP’S ASSESSMENT: False. There is no evidence that ...
via Bing News
